An international multicenter study, “TIPS” (thrombolysis in pediatric stroke), is poised to begin with the goal of assessing the safety of IV tPA within 3 hours of AIS onset, and intra-arterial tPA within 3–6 hours of onset [107]. The gene discussed is PLAT; the disease is stroke disorder.